Association between ALT flares and HBeAg loss and HBsAg decline in Patients with Chronic Hepatitis B during treatment with Tenofovir Disoproxil Fumarate or Adefovir Dipivoxil

Marcellin, PatrickGane, Edward J.Krastev, ZaharyGürel, SelimDusheiko, Geoffrey M.Gaggar, AnujMassetto, BenedettaKim, KyungpilFlaherty, John F.Subramanian, ManiJanssen, Harry L.Buti, Maria2024-08-012024-08-012015-10-010270-9139https://hdl.handle.net/11452/43612Bu çalışma, 13-17, Kasım 2015 tarihlerinde San Francisco[Amerika]’da düzenlenen 66. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessGastroenterology & hepatologyAssociation between ALT flares and HBeAg loss and HBsAg decline in Patients with Chronic Hepatitis B during treatment with Tenofovir Disoproxil Fumarate or Adefovir DipivoxilMeeting Abstract0003683754043011212A1212A62Supplement 1, Special Issue SI